
CLINICAL AND MOLECULAR DATA ON
MENTAL RETARDATION IN BULGARIA Todorov T1#, Todorova A1#, Avdjieva D2, Dimova P3,
Angelova L4, Tincheva R2 and Mitev V1 *Corresponding Author: Tihomir Todorov, Department of Medical Chemistry and Biochemistry,
Sofia Medical University, 2 “Zdrave” str., Sofia 1431, Bulgaria; Tel./Fax: +359 29530715;
tisho.todorov@abv.bg page: 11
|
MATERIALS AND METHODS
In total, 85 unrelated patients with MR were
included in the study. The clinical diagnoses were
as follows: 32 FXS male patients (aged between
2 and 26 years), 36 RTT girls (aged between 2
and 20 years), of whom 23 had classical RTT and
13 atypical RTT [with concomitant diagnosis of
autism, epilepsy, and West syndrome (OMIM#
308350)], PWS/AS, Pitt-Hopkins syndrome
(OMIM# 610954), 14 PWS (aged between 1 and
11 years), 10 boys and four girls (one of the boys
had a concomitant diagnosis of spinal muscular
atrophy (SMA, OMIM#253300) and three AS (aged
between 4 and 10 years, two girls and one boy). All
patients are of Bulgarian ethnicity.
The research protocol was approved by The
Ethics Committee for Research Investigations to
the Medical University, Sofia, Bulgaria. Informed
consent was obtained from the guardians of all
patients.
DNA samples were extracted from peripheral
blood, using DNA extraction kit (QIAamp DNA
Mini Kit; Qiagen, Hilden, Germany). The genetic
tests covered the genes FMR1, MECP2, CDKL5,
ARX, and methylation analysis of exon 1 of the
SNRPN. In addition, multiplex ligation-dependent
probe amplification (MLPA) analysis was used to
look for large deletions/duplications and to clarify
the methylation status of FMR1 and SNRPN
genes. The MLPA analysis proved to be useful in
clarifying mosaic FXS cases [10], in detecting large
deletions on the X-chromosome genes, as well as in
determining the type of mutation (deletion or UPD)
in PWS/AS cases.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|